A somewhat confusing article about what seems to be a fake Abbott Thyronorm levothyroxine in India.
Am posting for several reasons:
• Anyone who receives levothyroxine in, or directly or indirectly from, India needs to be aware.
• I posted about Acme being just about to get approval in Canada though Genix.
• Interest in the amazing scale in this claim: Almost 32% of Indians suffer from various kinds of thyroid disorders, specifically hypothyroidism and hyperthyroidism, according to a survey by SRL Diagnostics.
Other than the first, there really is no other reason to continue reading!
Popular thyroid drug comes under a cloud; company responds
Almost 32% of Indians suffer from various kinds of thyroid disorders, specifically hypothyroidism and hyperthyroidism, according to a survey
A popular drug used for hypothyroidism Thyronorm has been flagged as “Not of Standard Quality” by the Telangana drug controller.
The drug is however not the one produced by Abbott India, a unit of Chicago-based Abbott Laboratories which said the name Abbott was missing in entries made by the drug controller’s list and it only mentions that the drug was produced by “Acme Generics LLP” in Himachal Pradesh.
The drug controller’s report said the “sample does not comply with identification and assay of Thyroxine sodium tablets IP (Drug Nil),” as per the Indian Pharmacopoeia 2018, which along with the Central Drugs Standard Control Organisation (CDSCO) sets the standards for quality of drugs.
Rest of article - and you do need to read it carefully if you might be affected by the issues - available here:
This is not the 1st scandal surrounding levo produced in India is it? I think the last one was something about lack of controls cleaning the production line. I believe India are working hard to grow this area of revenue too.
"Almost 32% of Indians suffer from various kinds of thyroid disorders" Who knew!I've read quite a few thyroid studies from India..........should have realised really. I know that they have an awful lot of diabetics.........makes sense.
No - not the first problem in India. Though it could be that this is entirely a matter of fake and neither Abbott nor Acme have done anything wrong.
In which case, protection of supply chains would appear critical. Stop fake stuff getting distributed - which is what a lot of changes (e.g. to packaging), in many places, have been directed against. That and things like environmental control (temperature being so important for many medicines).
Now that you mention it my Aristo 100mcg packaging has just changed. Instead of 2 strips of 14 per box, all 28 are on the same strip. I've got to admit I didn't think anything of it. Maybe I should pay more attention in future.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.